Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Kutalek

Clinical Cardiac Electrophysiology Langhorne, PA Medical Doctor

NPI 1730137258 CMS profile 32729

1205 Langhorne Newtown Rd Ste 400, Langhorne, PA 19047

Open in the dashboard

General payments

$177,333

351 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$100,486 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Steven Kutalek of Langhorne, PA is reported in the CMS Open Payments database as having received $177,333 across 351 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $100,486 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,938 40
2024 General $19,792 43
2023 General $30,658 58
2022 General $27,705 74
2021 General $41,080 51
2020 General $7,330 29
2019 General $34,831 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Kutalek
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Steven Kutalek were reported at $15,938. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Steven Kutalek Clinical Cardiac Electrophysiology median Middle half National median
2019 $34,831 $2,361 $585–$8,260 $163
2020 $7,330 $993 $247–$4,351 $114
2021 $41,080 $1,185 $326–$4,739 $132
2022 $27,705 $2,073 $554–$6,789 $149
2023 $30,658 $2,568 $759–$8,159 $160
2024 $19,792 $2,557 $703–$7,403 $164
2025 $15,938 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Philips Electronics North America Corporation $51,407 63 payments
  2. Boston Scientific Corporation $42,056 95 payments
  3. Bardy Diagnostics, Inc. $38,840 33 payments
  4. Baxter Healthcare $36,209 30 payments
  5. Abbott Laboratories $4,265 17 payments
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $1,667 10 payments
  7. Medtronic, Inc. $488 8 payments
  8. MicroPort CRM USA Inc $256 7 payments
  9. Biotronik Inc. $215 4 payments
  10. Pfizer Inc. $215 13 payments
  11. Other $1,715 71 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $96,752 46 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50,500 18 payments
  3. Travel and Lodging $15,958 61 payments
  4. Food and Beverage $10,366 220 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $3,716 4 payments
  6. Education $42 2 payments
Products named General payments · program years 2019–2025
  1. Carnation Ambulatory Monitor $38,840 33 payments
  2. Hillrom - Carnation Ambulatory Monitor $36,000 25 payments
  3. (9520) IGT Devices Undivided $25,547 18 payments
  4. General Therapies Therapies $19,061 30 payments
  5. Bridge $14,709 4 payments
  6. CLINICAL TRIAL PRODUCT $4,820 5 payments
  7. Quartet CRT Lead $3,716 4 payments
  8. GENERAL THERAPIES Pain Management $3,350 7 payments
  9. General - Therapies $2,818 12 payments
  10. IGT Devices Undivided $2,688 7 payments
  11. Other $18,644 208 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

296

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$64,998

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

16.2%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 23 $26,291
Xarelto Rivaroxaban Brand 14 $14,967
Multaq Dronedarone Hcl Brand 11 $14,544
Dofetilide Generic 23 $4,131
Pindolol Generic 19 $1,677
Flecainide Acetate Generic 45 $1,296
Metoprolol Succinate Generic 38 $738
Propafenone Hcl Generic 11 $382
Diltiazem Hcl Generic 24 $276
Losartan Potassium Generic 13 $206

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$225,457

Medicare's payments for the services billed

Medicare patients

632

Average age 78

Services billed

2,391

289 women, 343 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 65%
Heart failure 60%
Arthritis 52%
Diabetes 45%
Chronic kidney disease 45%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ENTRESTO
  • Novartis Pharmaceuticals Corporation $54
$54 — —
VYNDAMAX
  • PFIZER INC. $29
$29 — —
ELIQUIS
  • PFIZER INC. $23
$23 23 —
XARELTO
  • Janssen Pharmaceuticals, Inc $17
$17 14 —
FARXIGA
  • AstraZeneca Pharmaceuticals LP $14
$14 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

351 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record